Skip to main content
. 2018 May 25;9(40):25935–25945. doi: 10.18632/oncotarget.25407

Figure 4.

Figure 4

(A) Drug targets were tested for their subtype specific expression by the Kruskal-Wallis test. Absolute quantification of transcript levels was based on normalized nCounter counts. (B) Immunohistochemistry of representative luminal, infiltrated and basal MIBC. (C, D) Gene set enrichment analyses of an immune signature from the Gene Ontology database.